Pamela Esposito insider trades: Kymera Therapeutics (KYMR) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Pamela reports to the SEC
Open-market buys and sales
20 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 20, 2026 | KYMR | ↓ Sell | 2,500 | $79.15 | $198K | Direct | Mar 20, 2026 (0d) |
| Feb 20, 2026 | KYMR | ↓ Sell | 2,500 | $87.31 | $218K | Direct | Feb 20, 2026 (0d) |
| Jan 20, 2026 | KYMR | ↓ Sell | 5,500 | $67.91 | $374K | Direct | Jan 20, 2026 (0d) |
| Dec 17, 2025 | KYMR | ↓ Sell | 27,563 | $82.16 | $2.3M | Direct | Dec 17, 2025 (0d) |
| Jun 3, 2025 | KYMR | ↓ Sell | 5,000 | $49.04 | $245K | Direct | Jun 3, 2025 (0d) |
| Dec 2, 2024 | KYMR | ↓ Sell | 2,500 | $49.00 | $123K | Direct | Dec 2, 2024 (0d) |
| Sep 17, 2024 | KYMR | ↓ Sell | 13,500 | $48.28 | $652K | Direct | Sep 17, 2024 (0d) |
| Sep 12, 2023 | REPL | ↓ Sell | 5,658 | $20.01 | $113K | Direct | Sep 13, 2023 (1d) |
| Aug 22, 2023 | REPL | ↓ Sell | 18,600 | $20.01 | $372K | Direct | Aug 24, 2023 (2d) |
| Aug 11, 2023 | REPL | ↓ Sell | 1,400 | $20.00 | $28K | Direct | Aug 15, 2023 (4d) |
| Jul 10, 2023 | REPL | ↓ Sell | 20,000 | $21.58 | $432K | Direct | Jul 11, 2023 (1d) |
| May 16, 2023 | REPL | ↓ Sell | 5,966 | $18.05 | $108K | Direct | May 18, 2023 (2d) |
| Dec 9, 2022 | REPL | ↓ Sell | 15,000 | $25.03 | $375K | Direct | Dec 13, 2022 (4d) |
| May 16, 2022 | REPL | ↓ Sell | 3,507 | $14.59 | $51K | Direct | May 18, 2022 (2d) |
| Aug 5, 2021 | REPL | ↓ Sell | 30,000 | $35.08 | $1.1M | Direct | Aug 6, 2021 (1d) |
| Jul 21, 2021 | REPL | ↓ Sell | 17,400 | $33.14 | $577K | Direct | Jul 22, 2021 (1d) |
| Jul 15, 2021 | REPL | ↓ Sell | 4,600 | $33.37 | $154K | Direct | Jul 19, 2021 (4d) |
| Jan 19, 2021 | REPL | ↓ Sell | 55,000 | $43.99 | $2.4M | Direct | Jan 19, 2021 (0d) |
| Oct 14, 2020 | REPL | ↓ Sell | 16,000 | $32.90 | $526K | Direct | Oct 16, 2020 (2d) |
| Aug 31, 2020 | REPL | ↓ Sell | 5,000 | $27.05 | $135K | Direct | Sep 1, 2020 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other KYMR insiders
Open-market trades in the last 12 months
About Pamela Esposito's insider trades
Pamela Esposito is an insider at Kymera Therapeutics (KYMR). Since Aug 31, 2020, Pamela has reported no open-market purchases and 20 sales worth $10.4M on SEC Form 4. In the last 12 months: 4 sales ($3.1M).
Their filings also include option exercises (23 filings), grants and awards (12 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KYMR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.